SCHEMBL13521823

SCHEMBL13521823

COc1ccc2cc(C(=O)NCCCCC(N)C(=O)O)c(=O)oc2c1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.62
▸ RXFP1 Q9HBX9 1/20 0.62
▸ ALDH1A1 P00352 6/20 0.59
▸ HPGD P15428 5/20 0.59
▸ KDM4E B2RXH2 5/20 0.59
▸ HSD17B10 Q99714 3/20 0.59
▸ GAA P10253 3/20 0.59
▸ GLA P06280 2/20 0.59
▸ AKR1B10 O60218 1/20 0.58
▸ AKR1B1 P15121 1/20 0.58
▸ CA12 O43570 3/20 0.58
▸ CA2 P00918 3/20 0.58
▸ CA4 P22748 3/20 0.58
▸ CA7 P43166 3/20 0.58
▸ CA1 P00915 2/20 0.58
▸ CA5A P35218 2/20 0.58
▸ CA5B Q9Y2D0 2/20 0.58
▸ SLC16A3 O15427 1/20 0.57
▸ RAB9A P51151 3/20 0.56
▸ TP53 P04637 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12801940 0.84 GPR55 (0.48) NPC1RXFP1ALDH1A1HPGDKDM4E
SCHEMBL12221078 0.83 ALDH1A1 (0.61) NPC1RXFP1ALDH1A1HPGDKDM4E
SCHEMBL1415893 0.83 NPC1 (0.69) NPC1RXFP1ALDH1A1HPGDKDM4E
SCHEMBL13521824 0.82 ALDH1A1 (0.60) NPC1ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL19158900 0.81 NPC1 (0.56) NPC1RXFP1ALDH1A1HPGDKDM4E
SCHEMBL6517660 0.79 AKR1B10 (0.52) NPC1RXFP1ALDH1A1HPGDKDM4E
Trifluoroacetic Acid SCHEMBL4412980 0.76 NPC1 (0.48) NPC1RXFP1ALDH1A1HPGDKDM4E
SCHEMBL20357069 0.76 NPC1 (0.52) NPC1RXFP1ALDH1A1HPGDKDM4E
SCHEMBL20370187 0.76 NPC1 (0.52) NPC1RXFP1ALDH1A1HPGDKDM4E
SCHEMBL19338224 0.75 ALDH1A1 (1.00) NPC1RXFP1ALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010000592-A2 CYCLOPEPTIDES USED AS MMP-TYPE PROTEASE ENZYME INHIBITORS COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2010-01-07 — — WO disclosed
Send feedback